We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$19B
AUM Growth
+$4.37B
Cap. Flow
+$3.05B
Cap. Flow %
16.07%
Top 10 Hldgs %
39.91%
Holding
1,362
New
110
Increased
730
Reduced
452
Closed
64

Sector Composition

Rank Sector Weight
1 Technology 35.28%
2 Financials 15.39%
3 Healthcare 5.04%
4 Energy 4.05%
5 Consumer Discretionary 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEM icon
1226
Newmont
NEM
$98.7B
$201K ﹤0.01%
+3,238
New +$184K
SKYW icon
1227
Skywest
SKYW
$4.24B
$201K ﹤0.01%
+5,127
New +$229K
SUPN icon
1228
Supernus Pharmaceuticals
SUPN
$2.59B
$201K ﹤0.01%
6,908
-1,589
-19% -$48.2K
BRKR icon
1229
Bruker
BRKR
$9.57B
$200K ﹤0.01%
+2,389
New +$192K
UNIT
1230
Uniti Group
UNIT
$2.36B
$200K ﹤0.01%
14,242
-2,779
-16% -$37K
HTBK
1231
DELISTED
Heritage Commerce
HTBK
$199K ﹤0.01%
16,633
-6,738
-29% -$78.7K
MAC icon
1232
Macerich
MAC
$7.33B
$198K ﹤0.01%
11,435
-1,907
-14% -$35.7K
BTU icon
1233
Peabody Energy
BTU
$2.6B
$195K ﹤0.01%
+19,408
New +$236K
HL icon
1234
Hecla Mining
HL
$9.47B
$187K ﹤0.01%
+35,829
New +$200K
AMRX icon
1235
Amneal Pharmaceuticals
AMRX
$5.85B
$179K ﹤0.01%
37,374
-575
-2% -$2.87K
TVRD
1236
Tvardi Therapeutics
TVRD
$19.7M
$173K ﹤0.01%
+394
New +$198K
ESPR
1237
DELISTED
Esperion Therapeutics
ESPR
$172K ﹤0.01%
+34,327
New +$275K
CARS icon
1238
Cars.com
CARS
$662M
$163K ﹤0.01%
+10,148
New +$145K
ATI icon
1239
ATI
ATI
$25.6B
$161K ﹤0.01%
+10,107
New +$162K
SBRA icon
1240
Sabra Healthcare REIT
SBRA
$5.34B
$161K ﹤0.01%
11,856
-2,096
-15% -$29.7K
CDE icon
1241
Coeur Mining
CDE
$15.4B
$149K ﹤0.01%
+29,612
New +$178K
ATRS
1242
DELISTED
Antares Pharma, Inc.
ATRS
$148K ﹤0.01%
41,422
-445
-1% -$1.56K
OCUL icon
1243
Ocular Therapeutix
OCUL
$1.79B
$140K ﹤0.01%
20,022
+3,988
+25% +$31K
DHC
1244
Diversified Healthcare Trust
DHC
$2.15B
$133K ﹤0.01%
43,128
+599
+1% +$1.94K
REE
1245
DELISTED
REE Automotive
REE
$127K ﹤0.01%
+762
New +$95.5K
XERS icon
1246
Xeris Biopharma Holdings
XERS
$1.39B
$127K ﹤0.01%
43,341
+14,174
+49% +$30.6K
ARAY icon
1247
Accuray
ARAY
$32M
$126K ﹤0.01%
26,367
+1,339
+5% +$6.45K
CCO icon
1248
Clear Channel Outdoor Holdings
CCO
$1.23B
$123K ﹤0.01%
37,172
-7,093
-16% -$22.1K
AERI
1249
DELISTED
Aerie Pharmaceuticals
AERI
$119K ﹤0.01%
+17,021
New +$178K
GNW icon
1250
Genworth Financial
GNW
$3.76B
$112K ﹤0.01%
27,591
-2,752
-9% -$11.4K

Similar funds

Rafferty Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Rafferty Asset Management held 1,362 positions worth $19B, up 30% from $14.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rafferty Asset Management deployed $3.05B of net new capital in Q4 2021, opening 110 new positions and adding to 730 existing holdings. Its largest new stake was Aflac: 345,009 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $81.8M trimmed.

  • Rafferty Asset Management's largest Q4 2021 buy was Aflac: 345,009 shares worth $20.1M.
  • Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $492M increase.
  • Rafferty Asset Management's biggest Q4 2021 reduction was VanEck Gold Miners ETF, cutting an estimated $81.8M.
  • Rafferty Asset Management fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $8.07M.
  • Rafferty Asset Management's ten largest holdings make up 40% of its $19B portfolio in Q4 2021.
  • Rafferty Asset Management opened 110 new positions and closed 64 in Q4 2021.
  • Rafferty Asset Management's portfolio value rose 30% quarter-over-quarter to $19B.

Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.